Recall that the plant is established in the regional center in early 2015 the company “Pharmasyntez” on the basis of which was in the process of bankruptcy “YugraFarm”. There are already producing infusion solutions. It is planned to establish production of hormones, which today is not Russia. For construction of this complex is prepared playground.
For the production of glucose-lowering drugs purchased Rotary Tablet and packaging line. Purchased and filling line for glass containers, and inspection machine for the creation of radiopaque agents. The volume of investments amounted to RUB 613.8 million. Finish the installation and commissioning of the equipment planned for the current year by March.
As part of the technical re-acquired as machine, Colloidal mill and various laboratory equipment, replaced the water treatment system. The amount of investments – 48.5 million rubles. The modernization of the boiler room, warehouse reconstruction, landscaping and drainage invested more than 15 million rubles. The company employs 217 people, has created an additional 32 new jobs.
Recall that at the meeting the governor Vladimir Yakushev and president of the company “Pharmasyntez” Vikram Singh Punii in 2015, the parties discussed not only the process of modernization and technical re-equipment of the enterprise, but also the promotion of the regional government in addressing infrastructure issues related to the implementation of the investment project.
Then Mr. Puniya stressed that conditions in the Tyumen region are favorable for business, and the head of the region, in turn, assured investors that the government will support the project.
“This investment project is very relevant. To some extent, it solves the problem of import of medicines, and most importantly – the company has experience in this direction “, – said Vladimir Yakushev.
JSC “Pharmasyntez” works in the market of medical products since 1997, its activities are primarily focused on the development and production of drugs for the treatment of socially significant diseases, such as tuberculosis, HIV / AIDS, cancer, blood diseases.
The company is a leader in the production of anti-TB drugs in Russia. Since 2011 she is in the top 10 leading pharmaceutical companies in Russia on the dynamics of the release of drugs. Production volume – 30 million units per year. Three plants in Irkutsk and Ussuriysk now shipped about 70 names of drugs in various dosage forms and dosage: capsules, tablets, granules, infusion solutions.
Add project is implemented with the support of Department of Investment Policy and State Support of Entrepreneurship of the Tyumen region.